The field of oral anticoagulation has evolved with the arrival of non‐vitamin K antagonist oral
anticoagulants (NOACs) including an anti‐IIa agent (dabigatran etexilate) and anti‐Xa …

New oral anticoagulants (NOACs) are increasingly replacing standard anticoagulants.
These new drugs have been recently introduced in clinical practice, and specific knowledge …

Dabigatran etexilate (DE), rivaroxaban, and apixaban are nonvitamin K antagonist oral
anticoagulants (NOACs) that have been compared in clinical trials with existing …

Objective To assess the safety aspects of regional anesthesia and analgesia, such as the
possible technique's complications; risk factors associated with spinal hematoma …

Objetivo Evaluar los aspectos de la seguridad en anestesia y analgesia regional en
pacientes en tratamiento con medicaciones antitrombóticas tales como: posibles …

Periprocedural Management of Patients on Anticoagulants - Clinics in Laboratory Medicine
Skip to Main Content Skip to Main Menu Advertisement Clinics in Laboratory Medicine Log in …

This review intends to provide guidance regarding perioperative management of
anticoagulation and antiplatelet drug therapy as they relate to foot and ankle surgery …

New oral anticoagulants (NOACs) are a major step forward in the field of anticoagulation. As
a consequence, the number of patients treated with NOACs that have to undergo surgery …

Les nouveaux anticoagulants oraux (NACOs) ont vu leurs indications croître ces dernières
années. Nombre de patients traités par ceux-ci doivent bénéficier d'une procédure …

Periprocedural Management of Patients on Anticoagulants Page 1 Periprocedural Management
of Patients on Anticoagulants Lance A. Williams III, MD a,*, James M. Hunter Jr, MD b, Marisa …